{"id":17295,"date":"2024-11-26T09:04:43","date_gmt":"2024-11-26T10:04:43","guid":{"rendered":"https:\/\/medexperts.pro\/?p=17295"},"modified":"2024-11-26T15:23:15","modified_gmt":"2024-11-26T15:23:15","slug":"biden-cuts-intels-chip-award","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=17295","title":{"rendered":"Biden Cuts Intel\u2019s Chip Award"},"content":{"rendered":"
<\/div>\n

The Silicon Valley company will receive less money from the CHIPS Act after winning a $3 billion military contract and changing some of its investment commitments.<\/p>\n

\n
\n
\n

The Biden administration said Tuesday that it would award up to $7.86 billion in direct funding to Intel, with the U.S. chip giant set to receive at least $1 billion of that money before the end of the year.<\/p>\n

The money is a reduction from Intel\u2019s preliminary award of $8.5 billion, which President Biden announced<\/a> during a visit to the company\u2019s Arizona plant in March. The Commerce Department said it had reduced Intel\u2019s grant because the chip maker, the biggest recipient of money under the CHIPS Act, also received a $3 billion contract to make semiconductors domestically for the military.<\/p>\n

But the Commerce Department also detailed in a project document that Intel, which is under financial pressure because of a sales slump, had extended timelines for some projects beyond a 2030 government deadline.<\/p>\n

The company now plans to invest $90 billion in the United States by the end of the decade, after previously saying it would spend $100 billion over the next five years. It also reduced the estimated jobs it would create in Ohio, where it will require 3,500 fewer employees than the 10,000 it previously estimated, the Commerce Department said.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

Commerce and Intel officials said those changes weren\u2019t a factor in the final award.<\/p>\n

Intel\u2019s shifting timeline and jobs projections speak to the challenges the Biden administration has run into as it tries to rev up domestic chip-making. The CHIPS Act, a bipartisan bill passed in 2022, provided $39 billion to subsidize the construction of facilities to help the United States reduce its reliance on foreign production of the tiny, critical electronics that power everything from dishwashers to iPads.<\/p>\n

Nailing down its CHIPS award has been a priority for Intel, which last month reported the biggest quarterly loss<\/a> in the company\u2019s 56-year history. It has been cutting costs and fending off takeover interest from rivals, after the total value of the company fell to around $107 billion, from $500 billion in 2000. (Other chip makers have also been facing challenges, because of a cyclical slump in the industry.)<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

The Silicon Valley company will receive less money from the CHIPS Act after winning a $3 billion military contract and changing some of its investment commitments.The Biden administration said Tuesday that it would award up to $7.86 billion in direct funding to Intel, with the U.S. chip giant set to receive at least $1 billion of that money before the end of the year.The money is a reduction from Intel\u2019s preliminary award of $8.5 billion, which President Biden announced during a visit to the company\u2019s Arizona plant in March. The Commerce Department said it had reduced Intel\u2019s grant because the chip maker, the biggest recipient of money under the CHIPS Act, also received a $3 billion contract to make semiconductors domestically for the military.But the Commerce Department also detailed in a project document that Intel, which is under financial pressure because of a sales slump, had extended timelines for some projects beyond a 2030 government deadline.The company now plans to invest $90 billion in the United States by the end of the decade, after previously saying it would spend $100 billion over the next five years. It also reduced the estimated jobs it would create in Ohio, where it will require 3,500 fewer employees than the 10,000 it previously estimated, the Commerce Department said.Commerce and Intel officials said those changes weren\u2019t a factor in the final award.Intel\u2019s shifting timeline and jobs projections speak to the challenges the Biden administration has run into as it tries to rev up domestic chip-making. The CHIPS Act, a bipartisan bill passed in 2022, provided $39 billion to subsidize the construction of facilities to help the United States reduce its reliance on foreign production of the tiny, critical electronics that power everything from dishwashers to iPads.Nailing down its CHIPS award has been a priority for Intel, which last month reported the biggest quarterly loss in the company\u2019s 56-year history. It has been cutting costs and fending off takeover interest from rivals, after the total value of the company fell to around $107 billion, from $500 billion in 2000. (Other chip makers have also been facing challenges, because of a cyclical slump in the industry.)We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":17297,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-17295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/17295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17295"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/17295\/revisions"}],"predecessor-version":[{"id":17298,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/17295\/revisions\/17298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/17297"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}